Literature DB >> 14961216

Quantitative ultrasound measurements in children and adolescents with: type 1 diabetes.

J Damilakis1, E Galanakis, D Mamoulakis, S Sbyrakis, N Gourtsoyiannis.   

Abstract

The aim of the current study was to evaluate bone status at the radius and phalanx in children and adolescents with type 1 diabetes by using quantitative ultrasound (QUS) measurements. Thirty pediatric patients, 16 male and 14 female, with type 1 diabetes of duration of 5 to 177 months and mean (+/- SD) age 11.3 +/- 4.6 years were studied. QUS measurements were carried out using the Sunlight Omnisense 7000 S device. Speed of sound (SOS) was measured at the radius and tibia. Diabetic control was assessed by glycosylated hemoglobin (HbA(1c)) measurements. Male and female patients with type 1 diabetes did not have significantly different SOS or HbA(1c) values. SOS Z-scores at both the radius and tibia were negatively associated with duration of disease ( r = -0 41 and r = -0.37 for the radius and tibia respectively, P < 0.05 for both correlations). Seven of 15 patients with duration of disease of >6 years had diminished SOS, defined as Z-score of <-1, at either the radius or tibia. SOS measurements at the radius showed moderate correlation with SOS at the tibia ( r = 0.58, P < 0.00 l). There was no correlation between SOS and HbA(1c). In conclusion, SOS Z-scores at both the radius and tibia show a significant negative correlation with duration of insulin-dependent diabetes in children. No relation was found between SOS and metabolic control of young diabetic patients.

Entities:  

Mesh:

Year:  2004        PMID: 14961216     DOI: 10.1007/s00223-003-0164-8

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  1 in total

1.  Bone status in adolescents with type 1 diabetes.

Authors:  A P Chobot; A Haffke; J Polanska; Z P Halaba; G Deja; P Jarosz-Chobot; W Pluskiewicz
Journal:  Diabetologia       Date:  2010-05-09       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.